Pyxis Oncology Inc (PYXS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -77,331 | -73,790 | -120,717 | -75,975 | -12,828 |
| Depreciation Amortization | -3,127 | -2,861 | 709 | 647 | 469 |
| Income taxes - deferred | -2,164 | 0 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 1,200 | -3,507 | -8,328 | 4,643 | 558 |
| Other Working Capital | -9,659 | -11,664 | 4,501 | 6,676 | 1,866 |
| Other Operating Activity | 33,409 | 21,113 | 34,500 | 28,683 | -149 |
| Operating Cash Flow | $-57,672 | $-70,709 | $-89,335 | $-35,326 | $-10,084 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 8,392 | -104,783 | N/A | N/A | N/A |
| PPE Investments | -237 | -6,726 | -6,399 | -540 | -1,483 |
| Net Acquisitions | N/A | 6,660 | N/A | N/A | N/A |
| Purchase Of Investment | N/A | N/A | N/A | -50 | N/A |
| Investing Cash Flow | $8,155 | $-104,849 | $-6,399 | $-590 | $-1,483 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 59,566 | 6,374 | 183 | 152,463 | 35 |
| Other Financing Activity | -240 | -445 | 0 | 151,581 | 0 |
| Financing Cash Flow | $59,326 | $5,929 | $183 | $304,044 | $35 |
| Beginning Cash Position | 11,136 | 180,765 | 276,316 | 8,188 | 19,720 |
| End Cash Position | 20,945 | 11,136 | 180,765 | 276,316 | 8,188 |
| Net Cash Flow | $9,809 | $-169,629 | $-95,551 | $268,128 | $-11,532 |
| Free Cash Flow | |||||
| Operating Cash Flow | -57,672 | -70,709 | -89,335 | -35,326 | -10,084 |
| Capital Expenditure | -237 | -6,726 | -6,399 | -540 | -1,483 |
| Free Cash Flow | -57,909 | -77,435 | -95,734 | -35,866 | -11,567 |